| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | DNA repair | WRN XRCC3 NSMCE3 FANCM APLF ATXN7L3 TAOK3 KIN ATXN7 OTUD4 PRMT1 BOD1L1 ATM HERC2 TDP1 CLSPN HDGFL2 VCPIP1 | 3.01e-06 | 648 | 160 | 18 | GO:0006281 |
| GeneOntologyBiologicalProcess | DNA metabolic process | DONSON PDGFB WRN NAP1L1 POLRMT XRCC3 NSMCE3 FANCM APLF ESCO1 FAM111B ATXN7L3 TAOK3 KIN ATXN7 OTUD4 PRMT1 BOD1L1 ATM HERC2 TDP1 CLSPN HDGFL2 VCPIP1 | 3.20e-06 | 1081 | 160 | 24 | GO:0006259 |
| Domain | RDM_domain_RFPL | 5.98e-06 | 5 | 159 | 3 | IPR022723 | |
| Domain | RDM | 5.98e-06 | 5 | 159 | 3 | PF11002 | |
| Domain | SPRY | 9.90e-05 | 87 | 159 | 6 | SM00449 | |
| Domain | SPRY | 1.52e-04 | 94 | 159 | 6 | PF00622 | |
| Domain | SPRY_dom | 1.52e-04 | 94 | 159 | 6 | IPR003877 | |
| Domain | B30.2/SPRY | 1.61e-04 | 95 | 159 | 6 | IPR001870 | |
| Domain | B302_SPRY | 1.61e-04 | 95 | 159 | 6 | PS50188 | |
| Domain | HEAT_type_2 | 3.77e-04 | 17 | 159 | 3 | IPR021133 | |
| Domain | SCA7 | 4.27e-04 | 4 | 159 | 2 | PF08313 | |
| Domain | SCA7_dom | 4.27e-04 | 4 | 159 | 2 | IPR013243 | |
| Domain | TF_AF4/FMR2 | 4.27e-04 | 4 | 159 | 2 | IPR007797 | |
| Domain | SCA7 | 4.27e-04 | 4 | 159 | 2 | PS51505 | |
| Domain | AF-4 | 4.27e-04 | 4 | 159 | 2 | PF05110 | |
| Domain | PRY | 4.40e-04 | 42 | 159 | 4 | PF13765 | |
| Domain | RCC1 | 6.21e-04 | 20 | 159 | 3 | PF00415 | |
| Domain | ARM-type_fold | RALGAPA1 USP24 CKAP5 TEX10 RALGAPA2 PPP4R4 RYR3 DOCK5 EIF4G2 ATM | 6.66e-04 | 339 | 159 | 10 | IPR016024 |
| Domain | RCC1_1 | 7.19e-04 | 21 | 159 | 3 | PS00625 | |
| Domain | RCC1_2 | 7.19e-04 | 21 | 159 | 3 | PS00626 | |
| Domain | RCC1_3 | 7.19e-04 | 21 | 159 | 3 | PS50012 | |
| Domain | PRY | 7.35e-04 | 48 | 159 | 4 | SM00589 | |
| Domain | PRY | 7.35e-04 | 48 | 159 | 4 | IPR006574 | |
| Domain | - | 8.28e-04 | 22 | 159 | 3 | 2.130.10.30 | |
| Domain | Reg_chr_condens | 8.28e-04 | 22 | 159 | 3 | IPR000408 | |
| Domain | RCC1/BLIP-II | 9.46e-04 | 23 | 159 | 3 | IPR009091 | |
| Domain | SPOC_C | 1.06e-03 | 6 | 159 | 2 | IPR012921 | |
| Domain | SPOC | 1.06e-03 | 6 | 159 | 2 | PF07744 | |
| Domain | ALB/AFP/VDB | 1.06e-03 | 6 | 159 | 2 | IPR000264 | |
| Pubmed | RALGAPA1 KNTC1 VPS4B SLC43A1 TUT7 GPAT3 ZDBF2 TRIP4 SLC4A2 SPDL1 ZCCHC14 KIN ATAD1 PHF3 TMEM131L SECISBP2 BOD1L1 TANC1 CLSPN VCPIP1 | 2.96e-10 | 733 | 163 | 20 | 34672954 | |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | WRN PPIL4 TEX10 SRFBP1 PAPOLA PHF3 TMPO ZFR BOD1L1 SPEN HDGFL2 AFF4 | 1.09e-08 | 283 | 163 | 12 | 30585729 |
| Pubmed | KNTC1 NOP56 ACADVL MRPL47 CFL1 PARP8 MB COQ6 DNAH2 CAGE1 TEX10 STK31 HNRNPAB PPP4R4 ATXN7 CDK13 SYNE2 TMPO ZFR GNA12 BOD1L1 ATM ZBTB11 SPEN HDGFL2 | 1.72e-08 | 1442 | 163 | 25 | 35575683 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | HIVEP1 NOP56 BAZ2B EML4 CFL1 PPIL4 ZDBF2 NSMCE3 SRFBP1 FANCM HNRNPAB PHF3 EIF4G2 TMPO SYT1 ZFR BOD1L1 SPEN HDGFL2 AFF4 | 2.54e-08 | 954 | 163 | 20 | 36373674 |
| Pubmed | HIVEP1 VPS4B USP24 CKAP5 POLRMT ZDBF2 INPP5F SPDL1 PRR12 ARID5B ATF7IP2 ZBTB11 VCPIP1 | 1.00e-07 | 418 | 163 | 13 | 34709266 | |
| Pubmed | Evolutionary forces shape the human RFPL1,2,3 genes toward a role in neocortex development. | 1.01e-07 | 3 | 163 | 3 | 18656177 | |
| Pubmed | HIVEP1 PPIL4 L1TD1 FAM161B TEX10 SKIL PAPOLA CDK13 EIF4G2 SECISBP2 HERC2 HERC1 ZBTB11 SMAD7 VCPIP1 | 1.42e-07 | 591 | 163 | 15 | 15231748 | |
| Pubmed | MRPL47 WRN CKAP5 NAP1L1 POLRMT SRPK1 TEX10 SRFBP1 TRIP4 PRR12 ATXN7L3 ATXN7 CDK13 PHF3 TLN1 EIF4G2 OTUD4 PRMT1 TANC1 HERC2 ZBTB11 SPEN HDGFL2 AFF4 | 1.46e-07 | 1497 | 163 | 24 | 31527615 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | MYO7A BAZ2B DNAH2 CKAP5 FAM227B ESCO1 DNAH14 DOCK5 TLN1 ARID5B TMPO BOD1L1 ALB ATM ZBTB11 RBM43 | 4.28e-07 | 736 | 163 | 16 | 29676528 |
| Pubmed | TUT7 USP24 CKAP5 NAP1L1 POLRMT SRPK1 TEX10 PHF3 TLN1 SYNE2 ZFR ATM HERC2 ZBTB11 SPEN | 5.03e-07 | 653 | 163 | 15 | 22586326 | |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 5.20e-07 | 202 | 163 | 9 | 33005030 | |
| Pubmed | Lysosomal Signaling Licenses Embryonic Stem Cell Differentiation via Inactivation of Tfe3. | HSP90B2P NOP56 BAZ2B CFL1 L1TD1 FANCM APLF HNRNPAB ARID5B TMPO TDP1 | 5.37e-07 | 332 | 163 | 11 | 30595499 |
| Pubmed | WHRN CKAP5 ZCCHC14 SV2A PHF3 TLN1 OTUD4 BOD1L1 HERC3 ANKRD12 SPEN VCPIP1 | 5.57e-07 | 407 | 163 | 12 | 12693553 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | NOP56 TUT7 WRN CKAP5 POLRMT SRPK1 TEX10 HNRNPAB KIN CDK13 PHF3 HS2ST1 TMPO ZFR HERC2 ZBTB11 | 6.41e-07 | 759 | 163 | 16 | 35915203 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | NOP56 BAZ2B WRN CKAP5 SRFBP1 FANCM SKIL ESCO1 HNRNPAB DOCK5 PRR12 ATXN7L3 CDK13 PHF3 ARID5B EIF4G2 TMPO ZFR SPEN HDGFL2 VCPIP1 | 7.81e-07 | 1294 | 163 | 21 | 30804502 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | HIVEP1 EML4 USP24 CKAP5 NSMCE3 PAPOLA ATXN7 CDK13 PHF3 EIF4G2 OTUD4 TMPO ATM KAT6B SPEN VCPIP1 | 8.28e-07 | 774 | 163 | 16 | 15302935 |
| Pubmed | Genetic Screens Reveal FEN1 and APEX2 as BRCA2 Synthetic Lethal Targets. | 8.28e-07 | 157 | 163 | 8 | 30686591 | |
| Pubmed | 1.00e-06 | 5 | 163 | 3 | 10508838 | ||
| Pubmed | 1.00e-06 | 5 | 163 | 3 | 11850190 | ||
| Pubmed | NOP56 CFL1 USP24 NAP1L1 SPDL1 PTPN14 PHF3 TLN1 TMPO ZFR BOD1L1 SPEN VCPIP1 | 2.15e-06 | 549 | 163 | 13 | 38280479 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | KNTC1 HSP90B2P NOP56 MYO7A CFL1 DNAH2 CKAP5 NAP1L1 ADGRB3 GPAT3 SRPK1 TLN1 TMPO ZFR BOD1L1 HDGFL2 | 2.65e-06 | 847 | 163 | 16 | 35235311 |
| Pubmed | 3.49e-06 | 7 | 163 | 3 | 9949213 | ||
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | NOP56 MYO7A POLRMT TEX10 RYR3 IFIH1 TAOK3 TMPO ZFR ATM HERC1 HDGFL2 | 4.39e-06 | 497 | 163 | 12 | 36774506 |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | RALGAPA1 NOP56 CFL1 PPIL4 NAP1L1 CLIC4 TEX10 SRFBP1 HNRNPAB PHF3 TMPO PRMT1 ZFR BOD1L1 CLSPN ZBTB11 AFF4 | 4.47e-06 | 989 | 163 | 17 | 36424410 |
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | NOP56 USP24 NAP1L1 CLIC4 INPP5F TEX10 ATAD1 CDK13 SYNE2 TMPO BOD1L1 PLCG1 | 4.48e-06 | 498 | 163 | 12 | 36634849 |
| Pubmed | CFL1 PPIL4 NAP1L1 SPDL1 PAPOLA CDK13 PHF3 TLN1 TMPO ZFR BOD1L1 HDGFL2 | 5.27e-06 | 506 | 163 | 12 | 30890647 | |
| Pubmed | RFPL4 interacts with oocyte proteins of the ubiquitin-proteasome degradation pathway. | 5.56e-06 | 8 | 163 | 3 | 12525704 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | NOP56 EML4 CFL1 TUT7 PPIL4 CKAP5 NAP1L1 POLRMT CLIC4 SRPK1 TEX10 HNRNPAB PTPN14 TLN1 EIF4G2 PRMT1 ZFR TANC1 PLCG1 HERC2 | 5.92e-06 | 1353 | 163 | 20 | 29467282 |
| Pubmed | 6.01e-06 | 272 | 163 | 9 | 31010829 | ||
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | 6.72e-06 | 208 | 163 | 8 | 33230847 | |
| Pubmed | NOP56 EML4 CFL1 TUT7 WRN PPIL4 NAP1L1 SRPK1 TEX10 SRFBP1 TRIP4 CDK13 PHF3 TLN1 AKR1B10 OTUD4 TMPO PRMT1 HERC2 AFF4 | 7.19e-06 | 1371 | 163 | 20 | 36244648 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | NOP56 CFL1 CKAP5 NAP1L1 HNRNPAB PAPOLA TLN1 EIF4G2 TMPO PRMT1 ZFR BOD1L1 PLCG1 HDGFL2 AFF4 VCPIP1 | 9.04e-06 | 934 | 163 | 16 | 33916271 |
| Pubmed | WRN NSMCE3 TEX10 FANCM HNRNPAB PRR12 PHF3 ZFR BOD1L1 ATM SNAPC1 | 1.05e-05 | 453 | 163 | 11 | 29656893 | |
| Pubmed | HIVEP1 MYO7A USP24 DNAH2 GPAT3 ZDBF2 STK31 PPP4R4 ATXN7 SYNE2 ARID5B OTUD4 SPEN | 1.08e-05 | 638 | 163 | 13 | 31182584 | |
| Pubmed | 1.18e-05 | 10 | 163 | 3 | 17478428 | ||
| Pubmed | EML4 TUT7 POLRMT SRPK1 SLC4A2 FAM111B DOCK5 PRR12 TAOK3 CDK13 TANC1 CLSPN ZBTB11 | 1.31e-05 | 650 | 163 | 13 | 38777146 | |
| Pubmed | NOP56 TUT7 SHROOM2 TAOK3 KIN PAPOLA ARID5B EIF4G2 AEBP2 OTUD4 TMEM131L SYT1 BOD1L1 ANKRD12 PLCG1 HERC1 AFF4 | 1.47e-05 | 1084 | 163 | 17 | 11544199 | |
| Pubmed | 1.53e-05 | 233 | 163 | 8 | 37704626 | ||
| Pubmed | KNTC1 HIVEP1 ZNF680 BAZ2B INPP5D CKAP5 NAP1L1 HNRNPAB PRR12 TAOK3 CDK13 TLN1 EIF4G2 TMPO PRMT1 ZFR SPEN | 1.83e-05 | 1103 | 163 | 17 | 34189442 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | MYO7A CFL1 KSR2 POLRMT RALGAPA2 ZCCHC14 PRR12 TULP4 CDK13 TLN1 GNA12 TANC1 PLCG1 HERC2 HERC1 SPEN SMAD7 | 1.87e-05 | 1105 | 163 | 17 | 35748872 |
| Pubmed | PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation. | NOP56 MRPL47 NAP1L1 POLRMT SRPK1 SRFBP1 HNRNPAB PTPN14 CDK13 EIF4G2 OTUD4 SECISBP2 ZFR | 2.04e-05 | 678 | 163 | 13 | 30209976 |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 33186807 | ||
| Pubmed | The structural plasticity of SCA7 domains defines their differential nucleosome-binding properties. | 2.18e-05 | 2 | 163 | 2 | 20634802 | |
| Pubmed | Role of AKR1B10 and AKR1B8 in the pathogenesis of non-alcoholic steatohepatitis (NASH) in mouse. | 2.18e-05 | 2 | 163 | 2 | 34954342 | |
| Pubmed | Aldo-keto reductase family 1 member B8 is secreted via non-classical pathway. | 2.18e-05 | 2 | 163 | 2 | 25120755 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 21087085 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 8526877 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 36518763 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 18596239 | ||
| Pubmed | Impaired Barrier Function and Immunity in the Colon of Aldo-Keto Reductase 1B8 Deficient Mice. | 2.18e-05 | 2 | 163 | 2 | 33644071 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 30862693 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 16442497 | ||
| Pubmed | Functional expression of novel human and murine AKR1B genes. | 2.18e-05 | 2 | 163 | 2 | 21276782 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 11355014 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 31911858 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 32341095 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 7578036 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 8541228 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 29433908 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 25538260 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 24561991 | ||
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | NOP56 ACADVL MRPL47 TUT7 POLRMT GPAT3 ZDBF2 HNRNPAB FAM111B PTPN14 ATAD1 CDK13 SYNE2 TMPO SECISBP2 ZFR TANC1 HERC2 HERC1 VCPIP1 | 2.52e-05 | 1496 | 163 | 20 | 32877691 |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | NOP56 CFL1 TUT7 PPIL4 CKAP5 NAP1L1 POLRMT SRPK1 TEX10 HNRNPAB PTPN14 KIN PHF3 TMPO PRMT1 ZFR ALB SPEN | 2.72e-05 | 1257 | 163 | 18 | 36526897 |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | NOP56 TUT7 PPIL4 NAP1L1 POLRMT SRPK1 SRFBP1 HNRNPAB CDK13 EIF4G2 OTUD4 PRMT1 ZFR SPEN | 2.93e-05 | 807 | 163 | 14 | 22681889 |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 3.00e-05 | 256 | 163 | 8 | 33397691 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | HIVEP1 ZNF680 BAZ2B WRN PHF3 TMPO BOD1L1 HERC2 ZBTB11 SPEN HDGFL2 AFF4 | 3.24e-05 | 608 | 163 | 12 | 36089195 |
| Pubmed | WHRN NOP56 MYO7A NAP1L1 SRPK1 DOCK5 PRR12 PAPOLA OTUD4 TMPO HERC2 | 3.31e-05 | 513 | 163 | 11 | 25798074 | |
| Pubmed | 3.43e-05 | 339 | 163 | 9 | 30415952 | ||
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 3.86e-05 | 430 | 163 | 10 | 35044719 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | NOP56 EML4 PPIL4 CKAP5 NSMCE3 TRIP4 KIN PHF3 TLN1 OTUD4 SECISBP2 ZFR SPEN | 4.01e-05 | 724 | 163 | 13 | 36232890 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | KNTC1 HIVEP1 NOP56 CFL1 PPIL4 CKAP5 NAP1L1 POLRMT HNRNPAB SPDL1 TLN1 EIF4G2 TMPO PRMT1 ZFR BOD1L1 PLCG1 ATM SPEN | 4.23e-05 | 1425 | 163 | 19 | 30948266 |
| Pubmed | 4.83e-05 | 201 | 163 | 7 | 25192599 | ||
| Pubmed | 5.79e-05 | 281 | 163 | 8 | 24163370 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | RALGAPA1 HIVEP1 PARP8 CKAP5 INPP5F PPP4R4 ZCCHC14 PTPN14 PHF3 SYNE2 BOD1L1 TANC1 CCDC102A VCPIP1 | 5.88e-05 | 861 | 163 | 14 | 36931259 |
| Pubmed | The PARP3- and ATM-dependent phosphorylation of APLF facilitates DNA double-strand break repair. | 6.53e-05 | 3 | 163 | 2 | 23449221 | |
| Pubmed | 6.53e-05 | 3 | 163 | 2 | 23438602 | ||
| Pubmed | 6.53e-05 | 3 | 163 | 2 | 24022220 | ||
| Pubmed | Substrate specificity and catalytic efficiency of aldo-keto reductases with phospholipid aldehydes. | 6.53e-05 | 3 | 163 | 2 | 17381426 | |
| Pubmed | 6.53e-05 | 3 | 163 | 2 | 22908222 | ||
| Pubmed | 6.53e-05 | 3 | 163 | 2 | 7510692 | ||
| Pubmed | ATM pathway activation limits R-loop-associated genomic instability in Werner syndrome cells. | 6.53e-05 | 3 | 163 | 2 | 30657978 | |
| Pubmed | 6.53e-05 | 3 | 163 | 2 | 23023331 | ||
| Pubmed | 6.53e-05 | 3 | 163 | 2 | 27536941 | ||
| Pubmed | 6.53e-05 | 3 | 163 | 2 | 30219864 | ||
| Pubmed | 6.53e-05 | 3 | 163 | 2 | 15654330 | ||
| Pubmed | 6.53e-05 | 3 | 163 | 2 | 19520869 | ||
| Pubmed | HERC2-USP20 axis regulates DNA damage checkpoint through Claspin. | 6.53e-05 | 3 | 163 | 2 | 25355518 | |
| Pubmed | HERC2 inactivation abrogates nucleolar localization of RecQ helicases BLM and WRN. | 6.53e-05 | 3 | 163 | 2 | 33432007 | |
| Pubmed | 6.53e-05 | 3 | 163 | 2 | 21330300 | ||
| Pubmed | ATM phosphorylation of Nijmegen breakage syndrome protein is required in a DNA damage response. | 6.53e-05 | 3 | 163 | 2 | 10839545 | |
| Pubmed | 6.53e-05 | 3 | 163 | 2 | 25673844 | ||
| Pubmed | HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137. | 7.35e-05 | 148 | 163 | 6 | 32538781 | |
| Pubmed | RALGAPA1 NOP56 ACADVL MRPL47 POLRMT GPAT3 SRPK1 TRIP4 SLC4A2 PTPN14 TLN1 SYNE2 EIF4G2 TMPO TMEM131L TANC1 ATM HERC2 HDGFL2 | 7.43e-05 | 1487 | 163 | 19 | 33957083 | |
| Pubmed | Quantitative Proteomics Links the LRRC59 Interactome to mRNA Translation on the ER Membrane. | 7.45e-05 | 375 | 163 | 9 | 32788342 | |
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | NOP56 ACADVL COQ6 CKAP5 CLIC4 CDK13 TMPO PRMT1 ZFR SPEN HDGFL2 VCPIP1 | 7.63e-05 | 665 | 163 | 12 | 30457570 |
| Pubmed | Defective neuromuscular synaptogenesis in agrin-deficient mutant mice. | 7.83e-05 | 18 | 163 | 3 | 8653788 | |
| Pubmed | CKAP5 NAP1L1 ZDBF2 SPDL1 TLN1 SYNE2 EIF4G2 TMPO TMEM131L TANC1 VCPIP1 | 8.22e-05 | 568 | 163 | 11 | 37774976 | |
| Pubmed | 9.01e-05 | 222 | 163 | 7 | 37071664 | ||
| Pubmed | Genetic mapping of five mouse genes encoding synaptotagmins. | 9.27e-05 | 19 | 163 | 3 | 8747928 | |
| Pubmed | 9.79e-05 | 225 | 163 | 7 | 12168954 | ||
| GeneFamily | AF4/FMR2 family|Super elongation complex | 1.84e-04 | 4 | 101 | 2 | 1145 | |
| GeneFamily | AF4/FMR2 family|Super elongation complex | 1.08e-03 | 9 | 101 | 2 | 1280 | |
| GeneFamily | X-linked mental retardation|RNA helicases | 1.64e-03 | 11 | 101 | 2 | 1168 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 2.74e-03 | 50 | 101 | 3 | 1293 | |
| GeneFamily | Zinc fingers|Zinc fingers PARP-type|Poly(ADP-ribose) polymerases | 3.09e-03 | 15 | 101 | 2 | 26 | |
| GeneFamily | Aldo-keto reductases | 3.09e-03 | 15 | 101 | 2 | 399 | |
| GeneFamily | Dyneins, axonemal | 3.98e-03 | 17 | 101 | 2 | 536 | |
| GeneFamily | OTU domain containing | 3.98e-03 | 17 | 101 | 2 | 669 | |
| GeneFamily | Lysine acetyltransferases|ATAC complex|SAGA complex|GCN5 related N-acetyltransferases | 3.98e-03 | 17 | 101 | 2 | 1059 | |
| GeneFamily | Synaptotagmins | 3.98e-03 | 17 | 101 | 2 | 765 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | RALGAPA1 KNTC1 WRN USP24 CKAP5 CLIC4 RALGAPA2 TULP4 TLN1 ATM HERC1 | 1.72e-08 | 180 | 162 | 11 | M8239 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | HIVEP1 BAZ2B WRN USP24 CKAP5 INPP5F TAOK3 MGAT5 KIN CDK13 PHF3 SYNE2 ARID5B OTUD4 TMEM131L TRAM2 KAT6B ZBTB11 SPEN SMAD7 | 3.64e-07 | 856 | 162 | 20 | M4500 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | RALGAPA1 MYO7A EML4 CFL1 INPP5D PARP8 USP24 SH3BP1 NAP1L1 TAOK3 PAPOLA ATXN7 CDK13 PHF3 TLN1 EIF4G2 OTUD4 TMEM131L SECISBP2 ZFR BOD1L1 PLCG1 ATM HERC1 KAT6B SPEN SMAD7 | 4.77e-07 | 1492 | 162 | 27 | M40023 |
| Coexpression | NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_DN | HIVEP1 EML4 PPIL4 ZDBF2 RALGAPA2 ESCO1 MGAT5 ATXN7 PHF3 TMPO ZFR BOD1L1 HERC3 TBC1D23 ZBTB11 AFF4 SMAD7 | 1.17e-06 | 680 | 162 | 17 | M41089 |
| Coexpression | MENON_FETAL_KIDNEY_0_CAP_MESENCHYME_CELLS | 1.47e-06 | 90 | 162 | 7 | M39250 | |
| Coexpression | GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_3H_DN | RALGAPA1 BAZ2B PARP8 ZCCHC14 TULP4 ARID5B HERC1 ZBTB11 VCPIP1 | 2.85e-06 | 189 | 162 | 9 | M8275 |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | KNTC1 BAZ2B TUT7 WRN PPIL4 NAP1L1 L1TD1 SPDL1 IFIH1 TAOK3 ABCA5 PHF3 SYNE2 ATM SNAPC1 ZBTB11 | 3.36e-06 | 656 | 162 | 16 | M18979 |
| Coexpression | GSE41867_NAIVE_VS_DAY6_LCMV_EFFECTOR_CD8_TCELL_DN | 4.53e-06 | 200 | 162 | 9 | M9463 | |
| Coexpression | GSE17301_ACD3_ACD28_VS_ACD3_ACD28_AND_IFNA2_STIM_CD8_TCELL_DN | RALGAPA1 HIVEP1 CASP4 ZCCHC14 IFIH1 TAOK3 ATF7IP2 TRAM2 SMAD7 | 4.53e-06 | 200 | 162 | 9 | M8040 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | HIVEP1 BAZ2B WRN USP24 CKAP5 INPP5F MGAT5 CDK13 PHF3 ARID5B TRAM2 KAT6B SPEN | 7.05e-06 | 466 | 162 | 13 | M13522 |
| Coexpression | GSE40274_SATB1_VS_FOXP3_AND_SATB1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN | 1.06e-05 | 121 | 162 | 7 | M9157 | |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | BAZ2B USP24 ZCCHC14 PHF3 ARID5B OTUD4 TMEM131L KAT6B SPEN SMAD7 | 1.86e-05 | 300 | 162 | 10 | M8702 |
| Coexpression | NUYTTEN_NIPP1_TARGETS_DN | PDGFB PARP8 RALGAPA2 SHROOM2 FAM111B ZCCHC14 PAPOLA TMTC4 TULP4 SYNE2 ATP2C2 EIF4G2 TMPO SNAPC1 CLSPN ADGRF1 MXD1 | 2.04e-05 | 845 | 162 | 17 | M18090 |
| Coexpression | GSE3982_MEMORY_CD4_TCELL_VS_TH2_UP | 3.13e-05 | 196 | 162 | 8 | M5381 | |
| Coexpression | ERBB2_UP.V1_DN | 3.25e-05 | 197 | 162 | 8 | M2635 | |
| Coexpression | GSE17301_IFNA2_VS_IFNA2_AND_ACD3_ACD28_STIM_CD8_TCELL_UP | 3.62e-05 | 200 | 162 | 8 | M8042 | |
| Coexpression | ZWANG_CLASS_1_TRANSIENTLY_INDUCED_BY_EGF | WRN L1TD1 SKIL STK31 DOCK5 DENND2C ATP2C2 ARID5B TMEM131L HERC3 ANKRD12 SNAPC1 AFF4 | 4.00e-05 | 550 | 162 | 13 | M2611 |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_3DY_DN | PARP8 PPIL4 ZDBF2 MGAT5 PAPOLA ATXN7 PHF3 HERC3 KAT6B ZBTB11 AFF4 | 8.28e-05 | 432 | 162 | 11 | M41149 |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_3DY_NEGATIVE | RALGAPA1 EML4 ESCO1 ATXN7 SYNE2 ATF7IP2 ZFR ANKRD12 KAT6B AFF4 | 9.21e-05 | 363 | 162 | 10 | M41103 |
| Coexpression | FISCHER_DREAM_TARGETS | KNTC1 ZNF680 WRN CKAP5 NAP1L1 CLIC4 XRCC3 FANCM HNRNPAB SPDL1 FAM111B IFIH1 CEP20 HS2ST1 TMPO TDP1 CLSPN | 1.10e-04 | 969 | 162 | 17 | M149 |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP | NOP56 MRPL47 CKAP5 CASP4 CLIC4 SRPK1 PSPH IFIH1 PAPOLA EIF4G2 TMPO BOD1L1 ZBTB11 AFF4 | 1.63e-04 | 721 | 162 | 14 | M10237 |
| Coexpression | GSE13738_RESTING_VS_BYSTANDER_ACTIVATED_CD4_TCELL_UP | 2.12e-04 | 194 | 162 | 7 | M3321 | |
| Coexpression | GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_UP | 2.19e-04 | 195 | 162 | 7 | M7397 | |
| Coexpression | GSE17974_1H_VS_72H_UNTREATED_IN_VITRO_CD4_TCELL_UP | 2.33e-04 | 197 | 162 | 7 | M4237 | |
| Coexpression | GSE13411_IGM_VS_SWITCHED_MEMORY_BCELL_DN | 2.40e-04 | 198 | 162 | 7 | M3248 | |
| Coexpression | GSE44649_WT_VS_MIR155_KO_NAIVE_CD8_TCELL_UP | 2.40e-04 | 198 | 162 | 7 | M9778 | |
| Coexpression | GSE3982_BASOPHIL_VS_TH1_UP | 2.47e-04 | 199 | 162 | 7 | M5564 | |
| Coexpression | GSE43955_TGFB_IL6_VS_TGFB_IL6_IL23_TH17_ACT_CD4_TCELL_52H_DN | 2.55e-04 | 200 | 162 | 7 | M9668 | |
| Coexpression | GSE45881_CXCR6HI_VS_CXCR1LO_COLONIC_LAMINA_PROPRIA_UP | 2.55e-04 | 200 | 162 | 7 | M9889 | |
| Coexpression | GSE19888_ADENOSINE_A3R_INH_VS_TCELL_MEMBRANES_ACT_MAST_CELL_UP | 2.55e-04 | 200 | 162 | 7 | M7324 | |
| Coexpression | GSE17721_LPS_VS_POLYIC_12H_BMDC_UP | 2.55e-04 | 200 | 162 | 7 | M3814 | |
| Coexpression | GSE17721_CPG_VS_GARDIQUIMOD_4H_BMDC_UP | 2.55e-04 | 200 | 162 | 7 | M3883 | |
| Coexpression | GSE17721_LPS_VS_POLYIC_6H_BMDC_UP | 2.55e-04 | 200 | 162 | 7 | M3808 | |
| Coexpression | GSE3337_CTRL_VS_4H_IFNG_IN_CD8POS_DC_DN | 2.55e-04 | 200 | 162 | 7 | M5099 | |
| Coexpression | GSE22103_UNSTIM_VS_LPS_STIM_NEUTROPHIL_UP | 2.55e-04 | 200 | 162 | 7 | M7794 | |
| Coexpression | GSE3720_VD1_VS_VD2_GAMMADELTA_TCELL_WITH_LPS_STIM_UP | 2.55e-04 | 200 | 162 | 7 | M6352 | |
| Coexpression | GSE22432_CDC_VS_COMMON_DC_PROGENITOR_UP | 2.55e-04 | 200 | 162 | 7 | M7831 | |
| Coexpression | GSE7460_CTRL_VS_TGFB_TREATED_ACT_TCONV_DN | 2.55e-04 | 200 | 162 | 7 | M5695 | |
| Coexpression | GSE20715_0H_VS_6H_OZONE_LUNG_DN | 2.55e-04 | 200 | 162 | 7 | M4365 | |
| Coexpression | GSE40274_FOXP3_VS_FOXP3_AND_HELIOS_TRANSDUCED_ACTIVATED_CD4_TCELL_DN | 2.70e-04 | 143 | 162 | 6 | M9149 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | RALGAPA1 EML4 PARP8 USP24 ABCA5 CDK13 PHF3 SYNE2 ANKRD12 ATM HERC1 | 2.05e-10 | 199 | 163 | 11 | f0b0097df0026496470a80d8cc9375ffd8389b00 |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 1.45e-08 | 171 | 163 | 9 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | RALGAPA1 EML4 USP24 SYNE2 TMEM131L ANKRD12 HERC1 ZBTB11 SPEN | 3.29e-08 | 188 | 163 | 9 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.93e-08 | 197 | 163 | 9 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | BAZ2B NAP1L1 ABCC9 PHF3 SYNE2 ARID5B SECISBP2 BOD1L1 ANKRD12 | 5.37e-08 | 199 | 163 | 9 | c425e7975f492ed5cfcca022248adb627e1d27d4 |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 1.15e-07 | 156 | 163 | 8 | 1545169694f686d28648a68b552c2ae606599d66 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 3.59e-07 | 181 | 163 | 8 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 5.61e-07 | 192 | 163 | 8 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.84e-07 | 193 | 163 | 8 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.31e-07 | 195 | 163 | 8 | ed5f772c82d4dfd1c8735224446ec9feae3fb8c2 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.64e-07 | 200 | 163 | 8 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 7.64e-07 | 200 | 163 | 8 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-B_cells-Cycling_B_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.78e-06 | 156 | 163 | 7 | 203ef22eb76bd2b829b027c30af0557080f4006c | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig-Z|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.02e-06 | 159 | 163 | 7 | bf8ff9251bcb64b2b9d6dd93461aec97659686ec | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 2.29e-06 | 162 | 163 | 7 | b4535bcb3f469bc139e73f1122f4070013e5a1de | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM1_(8)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 7.26e-06 | 193 | 163 | 7 | e2b455387d1de7812305200a2041a0f4759a6f54 | |
| ToppCell | Hippocampus-Neuronal|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 7.51e-06 | 194 | 163 | 7 | 8aeb347b3024354c9505f4f0fddf0b843489dc6b | |
| ToppCell | T_cells-Treg_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 8.30e-06 | 197 | 163 | 7 | de5448fcdf4e433fc167496413abe5d0c8a5c6d8 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.57e-06 | 198 | 163 | 7 | 44417089b62056269cac38d3134ff209c05b7007 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.57e-06 | 198 | 163 | 7 | 28ef3fc4c17dcb765537b75917f7db78baa522db | |
| ToppCell | (02)_MMP9/10+-(2)_GFP_FOXI1|(02)_MMP9/10+ / shred by cell type by condition | 8.86e-06 | 199 | 163 | 7 | 18a7f9ced4364f45b184bd529f32ef02c27779d3 | |
| ToppCell | mild-MAIT|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.86e-06 | 199 | 163 | 7 | cbe1fb6d2c5fca7a1baf1ad20afcdf8e8e11bd84 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-Neutrophil-Neu_1|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.40e-05 | 142 | 163 | 6 | 191a13bba143ecdfc2bfd797c3ac191481388298 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-Neutrophil-Neu_1|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.46e-05 | 143 | 163 | 6 | b405dba9a83a99cc7b53ce71772bc52a0bbb0d4e | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Treg_cell_4|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 2.22e-05 | 154 | 163 | 6 | 1f8d127b657976656e4ec292f26d619943533b86 | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Myofibro_3|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.17e-05 | 164 | 163 | 6 | 583dda853cee9491dbdcb228c23d8deadc20eb08 | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-T_cells-TRGV2_gdT|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.75e-05 | 169 | 163 | 6 | 8caf7996796a2e2716e3855de855c903d6126bf2 | |
| ToppCell | 343B-Lymphocytic-NK_cells-Proliferating_NK_cell|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.75e-05 | 169 | 163 | 6 | 02fa66a91b8bd2bf971aec4f5ec58318b5bfdf14 | |
| ToppCell | Healthy_donor-MAIT|World / disease group, cell group and cell class (v2) | 4.13e-05 | 172 | 163 | 6 | 6524eb2be1c78700ad367e62624a4d7eb48b54f0 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L2/3_IT-L2/3_IT_VISp_Agmat|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.23e-05 | 53 | 163 | 4 | 3549c9cdb138b01295b6a9745062fa3e4bd2e5dc | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.70e-05 | 176 | 163 | 6 | 3766e0533b103ec92ac75eba3df02e287efc53fa | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-late_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.70e-05 | 176 | 163 | 6 | aa1bada2175d8370fc71939a607407155259d195 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.00e-05 | 178 | 163 | 6 | fcbbcc44271515de1969b4732b6441c012693d5f | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.16e-05 | 179 | 163 | 6 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-Treg_cell_4|343B / Donor, Lineage, Cell class and subclass (all cells) | 5.16e-05 | 179 | 163 | 6 | c09c3eed43d1aa3b7aa8f3021e6f2737840cde16 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell-T_cells_proliferating-T_cells_proliferating_L.1.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.02e-05 | 184 | 163 | 6 | 8260e688ec42a1374727bc85dceb7edd19a8b662 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells-B_cells_L.1.5.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.20e-05 | 185 | 163 | 6 | e913c64f9b4873443d88dce270f0b7b6d1b4cbce | |
| ToppCell | Fetal_29-31_weeks-Immune-enucleated_erythrocyte-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.20e-05 | 185 | 163 | 6 | e8f7da9641b6cf1db1093b4f301ce828fd3a529c | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 6.20e-05 | 185 | 163 | 6 | 7925519b855f76444a0b57382ce35d89457b0b14 | |
| ToppCell | HSPCs-Ery/Mk_prog.|World / Lineage and Cell class | 6.77e-05 | 188 | 163 | 6 | 5390089213cd6ee90dcdfd3c3f5b6765376cccf2 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.39e-05 | 191 | 163 | 6 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.39e-05 | 191 | 163 | 6 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.39e-05 | 191 | 163 | 6 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 7.61e-05 | 192 | 163 | 6 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD8+_T-MAIT|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.61e-05 | 192 | 163 | 6 | 892789bdba150ef9a8a0012de52545f2ff6a31f6 | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-MAIT|COVID-19_Mild / Disease group, lineage and cell class | 7.61e-05 | 192 | 163 | 6 | d47bd132e57f5b4bddcf3dfa399cee149eca7e44 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD8+_T-MAIT-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.61e-05 | 192 | 163 | 6 | 24ea8fdcca2695aeb2e4b88161184124b7d332c1 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-Tregs|lymph-node_spleen / Manually curated celltypes from each tissue | 7.61e-05 | 192 | 163 | 6 | 91a4d06e8d1d1fe2ce5f72668108513bd2a72c4d | |
| ToppCell | Healthy_donor-CD4+_Tcm|World / disease group, cell group and cell class (v2) | 7.61e-05 | 192 | 163 | 6 | 1603903454ba6bf65c8e13ede620e0b1e8fbd7ec | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD8+_T-MAIT-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.61e-05 | 192 | 163 | 6 | 44f440ee3842fe14665c4cd4f2aa48e7a5bbd9a8 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD8+_T-MAIT|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.61e-05 | 192 | 163 | 6 | 8d50ad8cfe3cb9f183188b08457756af0ce56ffe | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 7.83e-05 | 193 | 163 | 6 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif-A|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.83e-05 | 193 | 163 | 6 | ecbe1bd16df547427da5e69a3017300e766c2899 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-skeletal_muscle_satellite_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.83e-05 | 193 | 163 | 6 | 1aa3ab528605dc7b2fec46e759c9d1ee93d59b11 | |
| ToppCell | normal_Pleural_Fluid-T/NK_cells-CD8_low_T|T/NK_cells / Location, Cell class and cell subclass | 8.06e-05 | 194 | 163 | 6 | cf2480cc40f3c9be837b3934547e2ce30bd4fcd3 | |
| ToppCell | Healthy/Control-CD4+_Tcm|World / Disease group and Cell class | 8.06e-05 | 194 | 163 | 6 | cbdd1786305108cbeddea07a21120067d78c59a0 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM1_(8)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.06e-05 | 194 | 163 | 6 | fb80a0271ccb1cb3f954ebcf2c5945cb6adb6b8c | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m-Epithelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.29e-05 | 195 | 163 | 6 | f41a68b7c2621594db8d8952e301eeadc96be26f | |
| ToppCell | COVID-19_Severe|World / Disease condition and Cell class | 8.52e-05 | 196 | 163 | 6 | 450ac2aff89c5ca73b8bfbc80663e03be066931f | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-T_lymphocytic-T_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.52e-05 | 196 | 163 | 6 | 4a880a5d2c7047c050c7d6dd62186f35dc5c01f7 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.76e-05 | 197 | 163 | 6 | ef2d1f56acd0be43e69bba7f73f6909ba87f1cb3 | |
| ToppCell | T_cells-Treg_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 8.76e-05 | 197 | 163 | 6 | ec9398ae3577f61d6b1e6aba50ef4261aaaa7610 | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 8.76e-05 | 197 | 163 | 6 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | systemic_lupus_erythematosus-flare|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 9.01e-05 | 198 | 163 | 6 | 4c93ee921d56132d80832d8e94563f32ccf13bbc | |
| ToppCell | Control_saline-Epithelial_airway|Control_saline / Treatment groups by lineage, cell group, cell type | 9.01e-05 | 198 | 163 | 6 | e6863238e022ecfb6a8e3f4b7661b376e92c5d8f | |
| ToppCell | Control_saline-Epithelial_airway-airway_epithelial|Control_saline / Treatment groups by lineage, cell group, cell type | 9.01e-05 | 198 | 163 | 6 | e7aa42e5fbd42c68f50cda4a8f3aa464c862c007 | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 9.26e-05 | 199 | 163 | 6 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | mild-CD4+_T_naive|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.26e-05 | 199 | 163 | 6 | 3e4baaf4ee23f257d821194468102c00a8ad2f21 | |
| ToppCell | 10x5'v1-week_17-19-Lymphocytic_B-B_lineage-pre_B_progenitor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 9.26e-05 | 199 | 163 | 6 | be425e9cb90a73289026b1b7cb581e1c02a8985e | |
| ToppCell | LPS_IL1RA-Epithelial_airway-airway_epithelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 9.52e-05 | 200 | 163 | 6 | cf191104484bfb2b9f87de416b9453135f8833c1 | |
| ToppCell | Control_saline-Endothelial-Endothelial-FOXM1|Control_saline / Treatment groups by lineage, cell group, cell type | 9.52e-05 | 200 | 163 | 6 | 9bbc7b5561151f6ff65f40b3226271def732e5d9 | |
| ToppCell | LPS_IL1RA|World / Treatment groups by lineage, cell group, cell type | 9.52e-05 | 200 | 163 | 6 | a02fa5b3c4723a6eaa3c685588666c710478dd25 | |
| ToppCell | LPS_IL1RA-Epithelial_airway|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 9.52e-05 | 200 | 163 | 6 | a5ae33dd4dc1ff6e1a1eec22c4d523d5ab657607 | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_submucosal-gland|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 9.52e-05 | 200 | 163 | 6 | 68b0f987c4fb8078675475f4f1e71302f832ef69 | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_submucosal-gland-SMG_Duct|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 9.52e-05 | 200 | 163 | 6 | 1b527bebbca1ef8c52449e40beb9358e37494e04 | |
| ToppCell | VE|World / Condition, Cell_class and T cell subcluster | 9.52e-05 | 200 | 163 | 6 | 8ae7cb81de3ffac5acdf3466d4b516d80cac95d3 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Neuronal-Intermediate|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 9.52e-05 | 200 | 163 | 6 | a3fcd901cb281920f1bafdfd676399a6dc37355e | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-div2|World / Primary Cells by Cluster | 9.52e-05 | 200 | 163 | 6 | 4923d7a4f00853c4d76fc1cc0fa82d522a2302e7 | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-div2-5|World / Primary Cells by Cluster | 9.52e-05 | 200 | 163 | 6 | dc1c1506823eaa105f1532c6b5d4efa14e788314 | |
| ToppCell | COVID_vent-Lymphocytic-Proliferative_Lymphocyte-|COVID_vent / Disease condition, Lineage, Cell class and subclass | 9.52e-05 | 200 | 163 | 6 | 7e4c0db43a03ca11380a54f44a3cf1991e055b80 | |
| ToppCell | COVID-19-Lymphoid-Proliferating_CD8_T_cells|Lymphoid / Condition, Lineage and Cell class | 9.52e-05 | 200 | 163 | 6 | 4556bb626ca1a00a6db13d2adb35acb8ba848f9c | |
| ToppCell | COVID_vent-Lymphocytic-Proliferative_Lymphocyte|COVID_vent / Disease condition, Lineage, Cell class and subclass | 9.52e-05 | 200 | 163 | 6 | 9775ca7dedb76fcbb74f80f86b33c94e394c320a | |
| ToppCell | severe_influenza-B_cell|severe_influenza / disease group, cell group and cell class (v2) | 1.08e-04 | 128 | 163 | 5 | 92b250186d6bb08ce4f2f5cc4fb93928f6b92d3a | |
| ToppCell | (08)_Brush+PNEC-(2)_GFP_FOXI1|(08)_Brush+PNEC / shred by cell type by condition | 1.54e-04 | 138 | 163 | 5 | 817e3f639604ea95adae01e8685ffaa2e0aff7a8 | |
| ToppCell | P03-Hematopoietic-Erythroid|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.88e-04 | 144 | 163 | 5 | 2ee6a834860eac7ed004f366ab4fc38c4b80c905 | |
| ToppCell | P03-Hematopoietic-Erythroid-enucleate_erythrocyte|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.88e-04 | 144 | 163 | 5 | 9fa63904389f4d7163db22ea85ab721d8f6e8d99 | |
| Drug | (-)-depudecin; Down 200; 1uM; MCF7; HT_HG-U133A_EA | NOP56 USP24 NAP1L1 PSPH SKIL IFIH1 HS2ST1 SECISBP2 ATM KAT6B | 1.48e-06 | 196 | 162 | 10 | 874_DN |
| Drug | Metanephrine hydrochloride DL [881-95-8]; Down 200; 17.2uM; PC3; HG-U133A | ATG4A KNTC1 COQ6 NAP1L1 PAPOLA PHF3 ATP2C2 ZFR ANKRD12 KAT6B | 1.70e-06 | 199 | 162 | 10 | 1933_DN |
| Disease | Paraquat lung | 2.85e-05 | 2 | 158 | 2 | C2931434 | |
| Disease | Usher Syndrome, Type II | 2.82e-04 | 5 | 158 | 2 | C1568249 | |
| Disease | testosterone measurement | DCDC1 ACADVL EML4 TMPRSS11E TUT7 DNAH2 SERPINA2 DOCK5 MGAT5 CEP120 SV2A SYNE2 ARID5B AKR1B15 MINAR1 PLCG1 TRAM2 | 5.06e-04 | 1275 | 158 | 17 | EFO_0004908 |
| Disease | Hereditary retinal dystrophy | 5.88e-04 | 7 | 158 | 2 | C0154860 | |
| Disease | Malignant neoplasm of breast | UBD CFL1 LDHAL6B XRCC3 SHROOM2 ZCCHC14 PTPN14 TMTC4 SYNE2 BOD1L1 ATM HERC2 CLSPN KAT6B SPEN | 6.83e-04 | 1074 | 158 | 15 | C0006142 |
| Disease | Adenocarcinoma of lung (disorder) | 8.77e-04 | 206 | 158 | 6 | C0152013 | |
| Disease | symmetrical dimethylarginine measurement | 1.00e-03 | 9 | 158 | 2 | EFO_0006523 | |
| Disease | Graves Disease | 1.00e-03 | 9 | 158 | 2 | C0018213 | |
| Disease | alpha-1-antitrypsin measurement | 1.00e-03 | 9 | 158 | 2 | EFO_0008327 | |
| Disease | Secondary Biliary Cholangitis | 1.48e-03 | 42 | 158 | 3 | C0238065 | |
| Disease | Biliary cirrhosis | 1.48e-03 | 42 | 158 | 3 | C0023892 | |
| Disease | Biliary Cirrhosis, Primary, 1 | 1.48e-03 | 42 | 158 | 3 | C4551595 | |
| Disease | senile cataract (is_implicated_in) | 1.52e-03 | 11 | 158 | 2 | DOID:9669 (is_implicated_in) | |
| Disease | insulin sensitivity measurement, glucose homeostasis measurement | 1.59e-03 | 43 | 158 | 3 | EFO_0004471, EFO_0006896 | |
| Disease | colorectal cancer | CHRDL2 PDGFB ADGRB3 L1TD1 SHROOM2 SYT1 GNA12 TANC1 HERC2 SMAD7 | 1.60e-03 | 604 | 158 | 10 | MONDO_0005575 |
| Disease | ureteral obstruction (biomarker_via_orthology) | 1.81e-03 | 45 | 158 | 3 | DOID:5199 (biomarker_via_orthology) | |
| Disease | Primary biliary cirrhosis | 2.06e-03 | 47 | 158 | 3 | C0008312 | |
| Disease | Amino Acid Metabolism, Inherited Disorders | 2.14e-03 | 13 | 158 | 2 | C0750905 | |
| Disease | Amino Acid Metabolism, Inborn Errors | 2.14e-03 | 13 | 158 | 2 | C0002514 | |
| Disease | Cardiomyopathy, Dilated | 2.18e-03 | 48 | 158 | 3 | C0007193 | |
| Disease | Fibrosis | 2.46e-03 | 50 | 158 | 3 | C0016059 | |
| Disease | Cirrhosis | 2.46e-03 | 50 | 158 | 3 | C1623038 | |
| Disease | colonic neoplasm, overall survival | 2.49e-03 | 14 | 158 | 2 | EFO_0000638, EFO_0004288 | |
| Disease | caudate volume change measurement | 2.49e-03 | 14 | 158 | 2 | EFO_0021491 | |
| Disease | Uveal Melanoma | 2.90e-03 | 53 | 158 | 3 | EFO_1000616 | |
| Disease | hepatocellular carcinoma (is_implicated_in) | 2.97e-03 | 181 | 158 | 5 | DOID:684 (is_implicated_in) | |
| Disease | Small cell carcinoma of lung | 3.06e-03 | 54 | 158 | 3 | C0149925 | |
| Disease | sphingomyelin 14:0 measurement | 3.68e-03 | 17 | 158 | 2 | EFO_0010390 | |
| Disease | disease progression measurement | 4.32e-03 | 61 | 158 | 3 | EFO_0008336 | |
| Disease | cutaneous melanoma, hair color | 4.52e-03 | 62 | 158 | 3 | EFO_0000389, EFO_0003924 | |
| Disease | Meningioma | 4.59e-03 | 19 | 158 | 2 | C0025286 | |
| Disease | COVID-19 (is_marker_for) | 4.73e-03 | 63 | 158 | 3 | DOID:0080600 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DLKEHLQKTVKKLPA | 1421 | Q8WWZ7 | |
| EELPAILKHKKSLQK | 141 | Q6ZT62 | |
| HIKVKKLLFSKHLPV | 66 | Q9UKF5 | |
| HELAGISKAPKKTKI | 401 | Q96M60 | |
| TRSKSKHELKLLEKI | 496 | P04920 | |
| AKRKEDSGKIKLLLH | 436 | Q6ZN18 | |
| KTKVVHLSKLPKDTA | 471 | Q6ZN18 | |
| LLPKLHIVKVVAKKY | 191 | Q9Y696 | |
| ILGKQHLLKTEKSKL | 31 | Q8WYN0 | |
| KDAIKKKLTGIKHEL | 121 | P23528 | |
| TALVELVKHKPKATK | 551 | P02768 | |
| LVKHKPKATKEQLKA | 556 | P02768 | |
| KSLHLKKKTLDKEVI | 656 | Q8TC20 | |
| LGKVSKHKIATKRTP | 301 | Q8IW19 | |
| KKELIVNKKKHLGPV | 31 | Q5T601 | |
| KLVSRDGILDKKLKH | 1046 | O60242 | |
| HRKKPLKVLESLGKD | 6 | P49662 | |
| KASGQTLKIKKLHVK | 1981 | Q9UIF8 | |
| TQKIPETKALKHKLS | 601 | P51816 | |
| PAILKHKKSLQKLVS | 136 | Q9Y3L3 | |
| HDKKILLLEAGPKKV | 61 | Q9Y2Z9 | |
| DPKIKEIAAKHKKTA | 231 | O60218 | |
| ISAHKKPIDLKAIGK | 236 | O60706 | |
| KAQHEKPLSLKEKTK | 991 | Q6UB98 | |
| LELKIKDKEKTKHTP | 1116 | Q6UB98 | |
| LKDTLEKKGVLGHLK | 11 | Q96NB1 | |
| HVKDVKKIKIEHAPS | 511 | Q14004 | |
| SPKHKLKIIKALQES | 651 | O75185 | |
| LLKKQKAKHTLIGDI | 346 | Q8TBG4 | |
| RKTKKKKSHLSLVGT | 306 | Q14CW9 | |
| ELKPSSKAHLTKLKI | 286 | Q9UHB7 | |
| KANKLDHVVTIIKGK | 131 | Q99873 | |
| ETLVKDLKKKIPSLS | 126 | Q6ZSC3 | |
| LVEELGKKHTSKNLK | 316 | Q01804 | |
| PILKHLKDIKVKFSD | 191 | P55209 | |
| PHKAKTKKIVFEDEL | 106 | Q9H607 | |
| EKVPRIKHKKKGTVS | 81 | Q8WUA2 | |
| KKGRKLLHEKAAQIK | 321 | Q8WYB5 | |
| IVKIITKKLGEKYHK | 286 | O60870 | |
| PFKKIKDHLLLIKKV | 246 | M0R2J8 | |
| HKLLKVIRKKLVHKT | 111 | Q58FF3 | |
| ETHLPSKKKKVLLGV | 81 | O00567 | |
| LHNKKLSEKKVKSPL | 266 | Q8N3A8 | |
| AEIKKGLLHCTQKKI | 186 | A0AUZ9 | |
| SLLTKAKLHIKKLED | 96 | Q05195 | |
| TLEKKFGIHLKEIDK | 461 | Q96JG8 | |
| KKEHKKVKSTRDIVP | 191 | P42166 | |
| KRKKVLVHLGLLTKE | 266 | Q09328 | |
| LVNLAGSKLEKHKIK | 2286 | O95714 | |
| LEKKIDEHFKTSPKI | 441 | Q15034 | |
| KKKSKPLNLKIHSSV | 331 | Q6VAB6 | |
| KQTHIKPTKIVSLKK | 841 | Q8IYD8 | |
| LKKLTFEPHRSIKKV | 446 | Q15751 | |
| LHKIKICIKESGQKL | 2241 | Q15751 | |
| TKKIKLSGLALDHKV | 231 | O75387 | |
| KKPIFKKATVTLEDH | 161 | P01127 | |
| KLTPEEEAHLKKSAK | 356 | Q9BYZ2 | |
| PHKSLEEVFKAKLKE | 506 | Q96MY7 | |
| VSTAKHVFEKKLKPK | 1636 | P50748 | |
| HVFEKKLKPKLLKLT | 1641 | P50748 | |
| GSTTVKIVLKEKHKK | 236 | Q6WN34 | |
| KVLDPKKDVLTRLKH | 16 | Q2PPJ7 | |
| EVEVRVSKKPGHTKK | 136 | Q8N3Z3 | |
| SILHKCIKTLLEKKK | 226 | P78344 | |
| GTKKLTKKEILVHVL | 96 | C9JSJ3 | |
| HTPLDKLIGKKRKCS | 826 | O15265 | |
| LGKLKSLATKEKEDH | 1001 | A8MWY0 | |
| KKEPSVEEKLQKLHS | 466 | Q7Z4V5 | |
| VLQKKKKHSTEGVKL | 501 | P51003 | |
| PHLKSLLKKEVKSSK | 711 | Q8NFC6 | |
| KLKHKRSPGKVKDIS | 1456 | Q8NFC6 | |
| TGRKVVDLVKHLKKD | 191 | P20848 | |
| CHKTKLKSILEILSK | 1396 | Q13315 | |
| KTLLHTLCKLKGPKI | 1761 | Q14008 | |
| KNIKVAKKVVKTHEP | 66 | Q6UX52 | |
| LAELKKKVTAKIDHG | 141 | Q9H7D0 | |
| LKEHIADKKKLPILI | 286 | Q53EU6 | |
| HSKKKVLTPIKEKTL | 361 | Q8N960 | |
| KELADLKHVHGKLKK | 416 | Q96A19 | |
| HLDKKKKASEPGKVI | 346 | Q9BYX4 | |
| LVEKVKTVSIKKHFP | 301 | Q03113 | |
| DIFESKRGKKKVKLH | 416 | Q68D51 | |
| VKKHSSEELLPKAKK | 581 | Q0VDD8 | |
| KHEGIADKLLAKIAK | 356 | Q5U623 | |
| KPDILSIKLRKEKHE | 376 | Q9NYP3 | |
| ESTKKKLSQKKLVHE | 96 | Q5FWF5 | |
| PKVTKTADKHKDVII | 206 | Q9HC35 | |
| KVKGPAHKISLELDK | 131 | A6NNS2 | |
| PKIIRHKDKAKTADV | 2781 | Q8NDH2 | |
| KKIVKINELHEKGSK | 196 | Q6SJ93 | |
| ISKQLVKKGVKHVES | 291 | Q9P225 | |
| KKLERKSSKPHEDII | 746 | Q9Y2H2 | |
| TLPSKEVKHARKTLK | 421 | O00411 | |
| GIKQEHKVLISKEKS | 731 | Q56UN5 | |
| EKIVDKSTKGKHVKV | 56 | Q9BU68 | |
| LEKHEPVKKFKDKSI | 446 | Q9UPX6 | |
| GKLHKAVKKLRSELK | 206 | Q96PL5 | |
| LLPDKKKKFETKVHR | 186 | P21579 | |
| SHIKELEPKLKKILQ | 101 | O75677 | |
| EPVKKVLEKKFHTVS | 206 | Q99729 | |
| KVKSTLKIPADKHLL | 631 | Q6NUP7 | |
| KTINKVPTVKKEHLD | 41 | P12757 | |
| VKIQLVHGLKLVKTK | 361 | Q9BSW7 | |
| LKKVDTKPSSEKKIH | 1156 | A2VDJ0 | |
| VKKHLPKAHVKELIS | 1901 | Q8WXH0 | |
| SDDEKITRLLKKHKP | 246 | Q9C056 | |
| TGKKSHLRKTTEKKL | 281 | Q7LGA3 | |
| HLRKTTEKKLPTKQT | 286 | Q7LGA3 | |
| LDLIPVDEKKLKAHK | 21 | Q8TCY5 | |
| VELEKPLKKHLDKFA | 76 | Q15678 | |
| SKLEKETCKKLHPIL | 576 | Q96EA4 | |
| LKVDVESGKLIIKKS | 316 | Q92835 | |
| CLVKGSHKTLKLVVK | 91 | Q13796 | |
| LKHLKLKKLKCVIIS | 681 | Q96T21 | |
| LLTKKGVRVDHLDKK | 986 | Q9C0D5 | |
| PKNEHKTILKTLKDE | 746 | Q9H2K8 | |
| HAEAVKALKGSKKLV | 201 | Q9P202 | |
| VKHLLGKQLLKDKSI | 181 | Q14191 | |
| FTKKGDLKHITKLKP | 591 | Q96SB4 | |
| NLAGSKLEKHKIKKS | 1001 | Q9BVR0 | |
| EHKKKVLKRLSLSPA | 1891 | Q9ULL5 | |
| LERKKAKILLKKFPH | 226 | Q9HD33 | |
| EVKKHAAKKVVKGLD | 21 | Q7L0J3 | |
| KHVISVDKSKPDKAL | 191 | Q16533 | |
| VVEAKLIKHKKGIVN | 546 | P49748 | |
| DPKIKEIAAKHKKTT | 231 | C9JRZ8 | |
| TKVSGTKRIKHEIPK | 436 | Q14865 | |
| TDLKDTVILPIKKKH | 101 | Q8NBU5 | |
| HAKLKCIKEKSELKS | 61 | Q8WXI8 | |
| SHTKPGEKLQVLKAK | 586 | Q9HAW4 | |
| VDHLLSIKKTLKSLK | 626 | Q9BXU1 | |
| DPHSVKIKKINKTET | 156 | Q9UL52 | |
| TKPTVNEHDLLKLKK | 421 | O75351 | |
| ALSKHTKKKKLIAAV | 431 | Q5T4D3 | |
| LISSPHLGREKKKVK | 1371 | Q9NRJ4 | |
| KKIKEHVRSKTKVPV | 31 | O15205 | |
| KKPILLVHGDKREAK | 221 | Q9NUW8 | |
| DLKALTHSVLKKLKE | 91 | O15105 | |
| KKKPVSKHELVFVDT | 171 | O95625 | |
| KVLDTKKDALTRLKH | 16 | Q6GYQ0 | |
| KEGKVIDHTPVEKLK | 886 | Q96T58 | |
| VIKLLKEKFHFKKII | 161 | P78330 | |
| HPLLKKKIDVLKAAV | 106 | Q8NEF9 | |
| KETKILAKKPIHNSK | 171 | Q8NEF9 | |
| LAKKPIHNSKEKIAK | 176 | Q8NEF9 | |
| LRSHFIPTLEKLKKK | 3211 | Q15413 | |
| LHGEKVHLKEILSKK | 91 | Q8N0S2 | |
| IDIILKKKKSKDHFG | 396 | Q9Y490 | |
| ILDKISKRLHLSKVK | 96 | Q15035 | |
| VVKITSKKKHPELIT | 641 | Q9NUY8 | |
| KLLESQSKKKIHGKR | 2166 | Q9HCK1 | |
| LESKSVKSKHTKPVI | 481 | Q92576 | |
| DTVKHKVKILKRESG | 821 | Q92576 | |
| KRKILIKHKKLAEGS | 456 | P19174 | |
| ITKHKRKEPNKSIKH | 406 | Q9NXF1 | |
| ASHIKELEPKLKKIL | 161 | O75678 | |
| SHIKELEPKLKKILQ | 101 | O75679 | |
| KIILTGQKTKTLHKE | 691 | Q96JH7 | |
| KKHLIFGDPKKLITE | 211 | Q96MG7 | |
| ILKKKGHHEAEIKPL | 76 | P02144 | |
| KRPLGKHSKVSVEKI | 86 | Q8WYQ9 | |
| KHSKVSVEKIDLKGL | 91 | Q8WYQ9 | |
| HQKVVKLHTKLGKPI | 406 | Q96KR1 | |
| PRLKKDSVSLHKKFI | 856 | Q9UPU5 | |
| KSGLEKAIKHKDKLL | 256 | Q15650 | |
| IIKPAEKSLHEKLKQ | 491 | Q15063 | |
| EKEKVGRKGKHLLTV | 751 | Q5VYS8 | |
| THKLKSIIIGKSKLP | 221 | Q6NT04 | |
| STLIKHKKIHIEEKP | 251 | Q8NEM1 | |
| KGVKRKKIVAENHLK | 46 | P15822 | |
| KKIVAENHLKKIPKS | 51 | P15822 | |
| IKKAKLKSVKEVLHF | 16 | O43542 | |
| IITHPKLKTTAKKIL | 281 | Q9NYW5 | |
| SGLKKHLKTHKDEKP | 401 | Q8NC26 | |
| TGVTKLKKTEEKKHR | 581 | Q5T7N2 | |
| LVHLTLKKKSKLTEE | 1111 | Q13402 |